Bayer Intellectual Property GMBH et al v. ScieGen Pharmaceuticals, Inc.
| Bayer Intellectual Property GMBH, Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc. |
| ScieGen Pharmaceuticals, Inc. |
| 1:2023cv00335 |
| March 24, 2023 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 3, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 13 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2; 10,828,310 B2. (Attachments: #1 Order)(nms) |
Filing 12
SO ORDERED Granting (D.I. 151 in 21-md-3017-RGA; D.I. 11 in 23-cv-335-RGA) Stipulation of Dismissal. Signed by Judge Richard G. Andrews on 5/3/2023. Associated Cases: 1:23-cv-00335-RGA, 1:21-md-03017-RGA(nms)
|
| Filing 11 STIPULATION of Dismissal, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 5/3/2023 (nms). |
| CASE CLOSED per entry of D.I. #12 (nms) |
| CORRECTING ENTRY: The stipulation (D.I. 11) and Order (D.I. 12) filed on 5/3/2023, have been removed from the docket. It was realized after entry of the Order that the captions of the filings lacked reference to the MDL this case is a member of. The case has subsequently been reopened. Counsel is to refile an amended stipulation in both this case and the MDL (21md3017-RGA). (nms) |
| Filing 10 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by ScieGen Pharmaceuticals, Inc.. (Rogowski, Patricia) |
| DEFICIENCY NOTICE issued by the Court to Defendant: Pursuant to Fed. R. Civ. P. 7.1 (b)(1), A party must: (1) file the disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. Counsel is requested to supplement the docket with an appropriate Rule 7.1 Disclosure Statement. (nms) |
| Filing 9 NOTICE of Appearance by Patricia Smink Rogowski on behalf of ScieGen Pharmaceuticals, Inc. (Rogowski, Patricia) |
| Filing 8 WAIVER OF SERVICE returned executed by Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc., Bayer AG, Bayer Pharma AG: For ScieGen Pharmaceuticals, Inc. waiver sent on 3/28/2023, answer due 5/30/2023. (Fahnestock, Derek) |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:23-cv-00327-UNA, 1:23-cv-00334-UNA, 1:23-cv-00335-UNA(nms) |
| Remark: The MDL Panel has been notified of case opening. (mpb) |
| Filing 7 Summons Issued as to ScieGen Pharmaceuticals, Inc. on 3/24/2023. (mpb) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc.. (mpb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Intellectual Property GMBH, Bayer Pharma AG filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG. (mpb) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2; 10,828,310 B2. (mpb) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/18/2023. Date of Expiration of Patent: 2/17/2024 for U.S. Patent 9,539,218 and 1/31/2039 for U.S. Patent 10,828,310.Thirty Month Stay Deadline: 8/18/2025. (mpb) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) |
| Filing 1 COMPLAINT filed against ScieGen Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4097351.) - filed by Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc., Bayer AG, Bayer Pharma AG. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Civil Cover Sheet)(mpb) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
